In primary hepatocellular carcinoma, the TERT promoter mutation −124A is the most frequent genetic alteration in HCV-related and metabolic-related tumours and represents approximately 95% of all TERT promoter variations (Müller et al., 2020). This evidence concerns the gene TERT and hepatocellular carcinoma.